114 related articles for article (PubMed ID: 17048056)
1. Simultaneous resection of liver cell adenomas and an intrahepatic portosystemic venous shunt with elevation of serum PIVKA-II level.
Seyama Y; Sano K; Tang W; Kokudo N; Sakamoto Y; Imamura H; Makuuchi M
J Gastroenterol; 2006 Sep; 41(9):909-12. PubMed ID: 17048056
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Hepatocellular Adenoma with Elevated Serum Protein Induced by Vitamin K Absence/Antagonist-II in Adult Males.
Koya Y; Suzuki T; Tai M; Ichii O; Matsuhashi N; Ejiri Y; Miyazawa M; Shibata M; Harada M; Kumabe T; Nakashima O
Intern Med; 2019 Jun; 58(12):1739-1746. PubMed ID: 30799343
[TBL] [Abstract][Full Text] [Related]
3. The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma.
Kang KH; Kim JH; Kang SH; Lee BJ; Seo YS; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Gut Liver; 2015 Mar; 9(2):224-30. PubMed ID: 25473073
[TBL] [Abstract][Full Text] [Related]
4. Protein induced by vitamin K absence or antagonist II (PIVKA-II) producing large cell neuroendocrine carcinoma (LCNEC) of lung with multiple liver metastases: A case report.
Kurohama H; Mihara Y; Izumi Y; Kamata M; Nagashima S; Komori A; Matsuoka Y; Ueki N; Nakashima M; Ito M
Pathol Int; 2017 Feb; 67(2):105-109. PubMed ID: 28075042
[TBL] [Abstract][Full Text] [Related]
5. Des-gamma-carboxy prothrombin (PIVKA-II)-producing mediastinal embryonal carcinoma with features of hepatoid differentiation.
Hasegawa Y; Tomita K; Hashimoto K; Shigeoka Y; Watanabe M; Yamasaki A; Shimizu E
Anticancer Res; 2005; 25(6C):4569-71. PubMed ID: 16334143
[TBL] [Abstract][Full Text] [Related]
6. Liver cell adenoma in a young man with elevated serum PIVKA-II level.
Uto H; Shigehira M; Kawano T; Nagatomo H; Kuribayashi T; Taniguchi S; Koga K; Komada N; Kitamura T; Maruyama T; Tsubouchi H
J Gastroenterol; 1996 Jun; 31(3):441-5. PubMed ID: 8726839
[TBL] [Abstract][Full Text] [Related]
7. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.
Viggiani V; Palombi S; Gennarini G; D'Ettorre G; De Vito C; Angeloni A; Frati L; Anastasi E
Scand J Gastroenterol; 2016 Oct; 51(10):1257-62. PubMed ID: 27227515
[TBL] [Abstract][Full Text] [Related]
8. [False positive serum des-gamma-carboxy prothrombin after resection of hepatocellular carcinoma].
Hiramatsu K; Tanaka Y; Takagi K; Iida T; Takasaka Y; Mizokami M
Rinsho Byori; 2007 Apr; 55(4):330-7. PubMed ID: 17511263
[TBL] [Abstract][Full Text] [Related]
9. Association of multiple liver cell adenomas with spontaneous intrahepatic portohepatic shunt.
Kawakatsu M; Vilgrain V; Belghiti J; Flejou JF; Nahum H
Abdom Imaging; 1994; 19(5):438-40. PubMed ID: 7950822
[TBL] [Abstract][Full Text] [Related]
10. Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yoon YJ; Han KH; Kim DY
Scand J Gastroenterol; 2009; 44(7):861-6. PubMed ID: 19391065
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
[TBL] [Abstract][Full Text] [Related]
12. Liver resection for the treatment of a congenital intrahepatic portosystemic venous shunt.
Papamichail M; Ali A; Quaglia A; Karani J; Heaton N
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):329-33. PubMed ID: 27298112
[TBL] [Abstract][Full Text] [Related]
13. NX-PVKA levels before and after hepatectomy of hepatocellular carcinoma as predictors of patient survival: a preliminary evaluation of an improved assay for PIVKA-II.
Nanashima A; Abo T; Taura N; Shibata H; Ichikawa T; Takagi K; Arai J; Oyama S; Nagayasu T
Anticancer Res; 2013 Jun; 33(6):2689-97. PubMed ID: 23749928
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic aneurysmal portosystemic venous shunt: a case report and review of the literature.
Filik L; Boyacioglu S
Acta Medica (Hradec Kralove); 2006; 49(4):241-4. PubMed ID: 17438838
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma.
Fujiyama S; Morishita T; Sagara K; Sato T; Motohara K; Matsuda I
Hepatogastroenterology; 1986 Oct; 33(5):201-5. PubMed ID: 2433199
[TBL] [Abstract][Full Text] [Related]
16. [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve].
Kim MJ; Bae KW; Seo PJ; Jeong IK; Kim JH; Lee BH; Bang KT; Kim DW; Song IH
Korean J Hepatol; 2006 Sep; 12(3):404-11. PubMed ID: 16998292
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
Seo SI; Kim HS; Kim WJ; Shin WG; Kim DJ; Kim KH; Jang MK; Lee JH; Kim JS; Kim HY; Kim DJ; Lee MS; Park CK
World J Gastroenterol; 2015 Apr; 21(13):3928-35. PubMed ID: 25852278
[TBL] [Abstract][Full Text] [Related]
18. Unclassified hepatocellular adenoma with histological brown pigment deposition and serum PIVKA-II level elevation: a case report.
Hoshino K; Harimoto N; Muranushi R; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Araki K; Tomomasa R; Nobusawa S; Aishima S; Nakashima O; Shirabe K
Surg Case Rep; 2020 May; 6(1):94. PubMed ID: 32382834
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.
Kang SH; Kim DY; Jeon SM; Ahn SH; Park JY; Kim SU; Kim JK; Lee KS; Chon CY; Han KH
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):849-56. PubMed ID: 22495400
[TBL] [Abstract][Full Text] [Related]
20. [Clinical usefulness of plasma PIVKA-II assay and its limitations in patients with hepatocellular carcinoma].
Fujiyama S; Morishita T; Shibata J; Sato T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1129-38. PubMed ID: 2471453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
